| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Financial Outlook for the Full Year 2025For the fiscal year ending December 31, 2025, the Company now expects total revenue to ...
Stifel analyst Thomas Stephan reinstates Alphatec Holdings (NASDAQ:ATEC) with a Buy and announces $20 price target.
JP Morgan analyst Allen Gong initiates coverage on Alphatec Holdings (NASDAQ:ATEC) with a Overweight rating and announces Pr...
Wells Fargo analyst Vik Chopra maintains Alphatec Holdings (NASDAQ:ATEC) with a Overweight and raises the price target from ...
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...